Date Title Document
Date 12/12/24 Title Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb Document pdf
Date 12/05/24 Title Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day Document pdf
Date 12/02/24 Title Bausch Health Appoints New Chief Medical Officer and Head of R&D Document pdf
Date 11/18/24 Title Bausch Health and Salix to present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a new investigational product designed to address serious complications of cirrhosis Document pdf
Date 10/30/24 Title Bausch Health Announces Third Quarter 2024 Results Document pdf
Date 10/28/24 Title ACG Presidential Plenary to Highlight Analysis of Xifaxan® (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence Document pdf
Date 10/09/24 Title Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024 Document pdf
Date 10/08/24 Title Bausch Health and Salix survey highlights urgent need for improved understanding of liver disease across healthcare provider disciplines as prevalence of cirrhosis rises Document pdf
Date 08/13/24 Title Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners Document pdf
Date 08/01/24 Title Bausch Health Announces Second Quarter 2024 Results Document pdf
Date 07/24/24 Title Bausch Health Responds to Market Rumors Document pdf
Date 07/19/24 Title Bausch Health Welcomes Two New Members to the Executive Leadership Team Document pdf
Date 07/11/24 Title Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024 Document pdf
Date 06/20/24 Title Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals Document pdf
Date 06/14/24 Title Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences Document pdf
Date 05/23/24 Title Bausch Health, Canada Inc. announces additional public drug plan listings for PrUCERIS® (budesonide) aerosol foam to treat mild to moderate distal ulcerative colitis in adults Document pdf
Date 05/17/24 Title Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024 Document pdf
Date 05/15/24 Title Bausch Health Announces 2024 Annual Meeting of Shareholder Results Document pdf
Date 05/14/24 Title Bausch Health Announces Updates Related to Norwich XIFAXAN Matters Document pdf
Date 05/09/24 Title Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan® (rifaximin) Document pdf
Date 05/02/24 Title Bausch Health Announces First Quarter 2024 Results Document pdf
Date 04/11/24 Title Bausch Health to Announce First-Quarter 2024 Results on May 2 Document pdf
Date 04/11/24 Title Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029 Document pdf
Date 04/11/24 Title Acne vulgaris treatment PrARAZLO™ (tazarotene lotion, 0.045%) now available to patients through British Columbia PharmaCare public drug plan Document pdf
Date 04/05/24 Title Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals Document pdf
Date 04/03/24 Title Bausch Health, Canada Inc. announces first public drug plan listings for PrUCERIS® (budesonide) aerosol foam to help address the unmet need for the treatment of mild to moderate distal ulcerative colitis in adults Document pdf
Date 04/02/24 Title Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations Document pdf
Date 03/06/24 Title Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR® (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma Document pdf
Date 03/05/24 Title New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How to Prepare for the Procedure Document pdf
Date 03/01/24 Title Bausch Health Companies to Present at Cowen Annual Health Care Conference Document pdf
Date 02/22/24 Title Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results Document pdf
Date 02/12/24 Title Salix Announces 2024 Gastrointestinal Health Scholars Program Document pdf
Date 02/01/24 Title Bausch Health Announces Board Refreshment Document pdf
Date 02/01/24 Title Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22 Document pdf
Date 01/30/24 Title CABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S. Document pdf
Date 01/18/24 Title Solta Medical’s Thermage® FLX and TR-4 Return Pad Receive Registration Certifications in China Document pdf
Date 01/08/24 Title Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute Document pdf